April 07, 2003

United States of America Ex Rel v. Glaxcosmithkline PLC et al

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. September 04, 2012

    GSK Whistleblowers Slam 'Excessive' $30M Fee Request

    Two whistleblowers behind the record $3 billion False Claims Act settlement GlaxoSmithKline PLC inked in July over charges of kickbacks and misbranding drugs sought Friday to block their onetime legal counsel from winning $30 million in fees, calling the request unsubstantiated by a lien.


Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!